Literature DB >> 10576495

Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.

B Feige1, U Voderholzer, D Riemann, F Hohagen, M Berger.   

Abstract

OBJECTIVES: Habituation and adverse withdrawal reactions after prolonged medication with benzodiazepine (BZ) hypnotics are believed to play a role in dose escalation and the development of dependence.
METHODS: In the current sleep EEG study in 43 healthy male subjects, the known property of BZ- and similar hypnotics to change the NREM sleep EEG spectrum is utilized for a detailed quantitative analysis across 4 weeks of continuous medication and a subsequent two-week withdrawal period. The BZ hypnotic triazolam and the non-BZ hypnotics zopiclone and zolpidem, differing in pharmacological properties and reported adverse effects, were examined in parallel to a placebo group.
RESULTS: Reliably occurring spectral effects in the sleep stage 2 EEG were found in the 3 frequency bands 0.8-5 Hz, 5-10 Hz and 10-15 Hz. All 3 hypnotics showed the typical 'benzodiazepine signature', a 10-15 Hz increase and lower-frequency (<10 Hz) suppression relative to the preceding drug-free night. However, these effects developed differently across the first medication night, across the 4 medication weeks and after withdrawal: While the 5-10 Hz effect covaried with the blood presence of the drugs as estimated from the known plasma half-lifes, showed habituation and a rebound after withdrawal, the 10-15 Hz power increased across medication days and showed no rebound. Effects in the 0.8-5 Hz band in the first medication night correlated with the decrease of sleep efficiency at later withdrawal for triazolam and zolpidem.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576495     DOI: 10.1016/s1388-2457(99)00147-9

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  13 in total

Review 1.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

2.  Sleep Strengthens but does Not Reorganize Memory Traces in a Verbal Creativity Task.

Authors:  Nina Landmann; Marion Kuhn; Jonathan-Gabriel Maier; Bernd Feige; Kai Spiegelhalder; Dieter Riemann; Christoph Nissen
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

3.  Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults.

Authors:  Evan D Chinoy; Danielle J Frey; Daniel N Kaslovsky; Francois G Meyer; Kenneth P Wright
Journal:  Sleep Med       Date:  2014-05-23       Impact factor: 3.492

4.  Reference Data for Polysomnography-Measured and Subjective Sleep in Healthy Adults.

Authors:  Elisabeth Hertenstein; Agata Gabryelska; Kai Spiegelhalder; Christoph Nissen; Anna F Johann; Roza Umarova; Dieter Riemann; Chiara Baglioni; Bernd Feige
Journal:  J Clin Sleep Med       Date:  2018-04-15       Impact factor: 4.062

5.  Developmental changes in the sleep electroencephalogram of adolescent boys and girls.

Authors:  Fiona C Baker; Sharon R Turlington; Ian Colrain
Journal:  J Sleep Res       Date:  2011-06-13       Impact factor: 3.981

6.  The hypnotic zolpidem increases the synchrony of BOLD signal fluctuations in widespread brain networks during a resting paradigm.

Authors:  Stephanie C Licata; Lisa D Nickerson; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Neuroimage       Date:  2013-01-05       Impact factor: 6.556

7.  Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome.

Authors:  Fiona C Baker; Stephanie A Sassoon; Tracey Kahan; Latha Palaniappan; Christian L Nicholas; John Trinder; Ian M Colrain
Journal:  J Sleep Res       Date:  2012-03-14       Impact factor: 3.981

8.  Impact of alcoholism on sleep architecture and EEG power spectra in men and women.

Authors:  Ian M Colrain; Sharon Turlington; Fiona C Baker
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

9.  Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.

Authors:  Steven V Fox; Anthony L Gotter; Spencer J Tye; Susan L Garson; Alan T Savitz; Jason M Uslaner; Joseph I Brunner; Pamela L Tannenbaum; Terrence P McDonald; Robert Hodgson; Lihang Yao; Mark R Bowlby; Scott D Kuduk; Paul J Coleman; Richard Hargreaves; Christopher J Winrow; John J Renger
Journal:  Neuropsychopharmacology       Date:  2013-05-31       Impact factor: 7.853

Review 10.  Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.

Authors:  Masaomi Miyamoto
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.